Therefore, we hypothesized that FA attenuates HFD-induced hypercholesterolemia by activating Cyp7a1. Subsequently, by utilizing metabolomics, we found that two primary BAs in liver were significantly increased in HFD + FA group. The gene discussed is CYP7A1; the disease is familial hypercholesterolemia.